|
| |
|
Portfolio Analysis &
Optimization
R & D and Commercial |
|
With our unsurpassed
methodology and
process
we analyze R & D portfolios and balance risk and reward
based
on a mix of quantitative and qualitative
criteria. |
|
Key Objectives of the
Portfolio Analysis & Optimization Process
-
Value vs Cost
Understanding the potential value and associated costs of
compounds in the R&D pipeline
-
Depth of Understanding
gain concrete knowledge of the scientific and commercial
issues facing each compound in clinical development
-
Choices and Agreement
Prioritize late-stage and line-extension projects for
funding
Agree on those novel compounds which will continue to be
supported in early stages
-
Implications and Action
Understand the implications of these portfolio choices on
the operations and budgets of the company
|
|
The overall objective is to balance
a set
of financial and non-financial measures
-
Risk adjusted NPV
-
Peak Sales
-
Strategic Fit
-
Innovative / Scientific Value
(First in Class, Best in Class)
-
R & D
Productivity Index
-
Technical Probability of Success
-
Commercial Probability of Success
|
|
